
- /
- Supported exchanges
- / US
- / BIO.NYSE
Bio-Rad Laboratories Inc (BIO NYSE) stock market data APIs
Bio-Rad Laboratories Inc Financial Data Overview
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Bio-Rad Laboratories Inc data using free add-ons & libraries
Get Bio-Rad Laboratories Inc Fundamental Data
Bio-Rad Laboratories Inc Fundamental data includes:
- Net Revenue: 2 567 M
- EBITDA: 421 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-02-13
- EPS/Forecast: 2.8841
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Bio-Rad Laboratories Inc News

Bio-Rad Laboratories, Inc. (NYSE:BIO) is a favorite amongst institutional investors who own 60%
Key Insights Significantly high institutional ownership implies Bio-Rad Laboratories' stock price is sensitive to their trading actions The top 10 shareholders own 51% of the company 14% of Bio-Rad L...


Is Bio-Rad Laboratories, Inc. (BIO) the Best Medical Technology Stock to Buy According to Analysts?
We recently compiled a list of the 7 Best Medical Technology Stocks To Buy According To Analysts.In this article, we are going to take a look at where Bio-Rad Laboratories, Inc. (NYSE:BIO) stands agai...

Bio-Rad (BIO) International Revenue Performance Explored
Did you analyze how Bio-Rad Laboratories (BIO) fared in its international operations for the quarter ending December 2024? Given the widespread global presence of this maker of instruments used in bio...

HSIC Q4 Earnings Match Estimates, Margins Up, Stock Falls in Premarket
Henry Schein, Inc. HSIC registered adjusted earnings per share (EPS) of $1.19 in the fourth quarter of 2024, up 80.3% from the year-ago period’s EPS of 66 cents. The figure was in line with the Zack...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.